Drug profile · INN
ebola zaire vaccine (rvsv∆g-zebov-gp, live)
ERVEBO
ebola zaire vaccine (rvsv∆g-zebov-gp, live) (ERVEBO) is a envelope glycoprotein vaccine antigen.
EMA: approved
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — ebola zaire vaccine (rvsv∆g-zebov-gp, live)
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
ebola zaire vaccine (rvsv∆g-zebov-gp, live) (ERVEBO) is a envelope glycoprotein vaccine antigen.
Key facts
INN ebola zaire vaccine (rvsv∆g-zebov-gp, live)
Brand ERVEBO
Mechanism Envelope glycoprotein vaccine antigen
Target Envelope glycoprotein
Mechanism of action
Envelope glycoprotein vaccine antigen
Primary target: Envelope glycoprotein
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is ebola zaire vaccine (rvsv∆g-zebov-gp, live)?
ebola zaire vaccine (rvsv∆g-zebov-gp, live) (ERVEBO) is a envelope glycoprotein vaccine antigen.
What is the brand name for ebola zaire vaccine (rvsv∆g-zebov-gp, live)?
ERVEBO is a marketed brand name for ebola zaire vaccine (rvsv∆g-zebov-gp, live). Check FDA Drugs@FDA for the current US label holder and prescribing information.